Curi RMB Capital’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-1,640
Closed -$403K – 502
2022
Q3
$403K Hold
1,640
– – 0.02% 378
2022
Q2
$406K Sell
1,640
-3
-0.2% -$810 0.01% 377
2022
Q1
$544K Sell
1,643
-72
-4% -$22.2K 0.02% 323
2021
Q4
$616K Hold
1,715
– – 0.02% 337
2021
Q3
$558K Hold
1,715
– – 0.02% 336
2021
Q2
$535K Hold
1,715
– – 0.02% 350
2021
Q1
$547K Hold
1,715
– – 0.02% 344
2020
Q4
$556K Hold
1,715
– – 0.02% 413
2020
Q3
$475K Sell
1,715
-150
-8% -$43.2K 0.02% 427
2020
Q2
$451K Sell
1,865
-665
-26% -$134K 0.02% 419
2020
Q1
$367K Sell
2,530
-850
-25% -$141K 0.02% 453
2019
Q4
$577K Sell
3,380
-8,347
-71% -$1.55M 0.02% 429
2019
Q3
$2.09M Sell
11,727
-430
-4% -$92.9K 0.05% 291
2019
Q2
$3.17M Sell
12,157
-625
-5% -$166K 0.08% 245
2019
Q1
$3.65M Sell
12,782
-279
-2% -$92.7K 0.09% 235
2018
Q4
$4.25M Buy
13,061
+203
+2% +$70.5K 0.11% 209
2018
Q3
$5.78M Sell
12,858
-8,287
-39% -$3.27M 0.14% 184
2018
Q2
$8.65M Sell
21,145
-10,324
-33% -$3.74M 0.21% 136
2018
Q1
$9.16M Sell
31,469
-5,869
-16% -$1.49M 0.23% 127
2017
Q4
$7M Sell
37,338
-8,631
-19% -$1.61M 0.18% 165
2017
Q3
$7.75M Sell
45,969
-3,965
-8% -$600K 0.2% 158
2017
Q2
$7.16M Buy
49,934
+40,194
+413% +$5.4M 0.2% 157
2017
Q1
$1.22M Buy
9,740
+490
+5% +$56.8K 0.05% 283
2016
Q4
$1.04M Sell
9,250
-990
-10% -$115K 0.06% 246
2016
Q3
$1.32M Buy
10,240
+40
+0.4% +$4.79K 0.07% 220
2016
Q2
$1.11M Buy
10,200
+50
+0.5% +$4.97K 0.06% 228
2016
Q1
$962K Buy
+10,150
New +$857K 0.06% 227

Other funds holding ABMD

Curi RMB Capital's ABMD Position: Q4 2022 in Review

Curi RMB Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,640 shares — an estimated $403K sold.

Curi RMB Capital first reported a position in ABMD in Q1 2016 and held it in 27 quarters. The position peaked at $9.16M in Q1 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Curi RMB Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Curi RMB Capital sold 1,640 Abiomed Inc shares in Q4 2022, an estimated $403K.
  • Curi RMB Capital first reported a position in Abiomed Inc in Q1 2016 and held it in 27 quarters.
  • Curi RMB Capital's Abiomed Inc position peaked at $9.16M in Q1 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Curi RMB Capital's 13F filing for Q4 2022, filed 14 Feb 2023.